Industry:Biotech & Pharma
Valeant Pharmaceuticals International
Valeant Pharmaceuticals International (4107485Q:US)
was acquired by VRX:CN
Valeant Pharmaceuticals International operates as a research-based, specialty pharmaceutical company. The Company discovers, develops, manufactures, and markets a range of pharmaceutical products as well as focusing on products in the areas of infectious disease, neurology, and dermatology. Valeant Pharmaceuticals markets its products worldwide.